1-(2-chlorophenyl)-4-(2-pyridin-3-ylimidazol-1-yl)pyrrolidin-2-one

C18H15ClN4O — CID 70716243

IUPAC1-(2-chlorophenyl)-4-(2-pyridin-3-ylimidazol-1-yl)pyrrolidin-2-one
SMILESO=C1CC(n2ccnc2-c2cccnc2)CN1c1ccccc1Cl
InChIInChI=1S/C18H15ClN4O/c19-15-5-1-2-6-16(15)23-12-14(10-17(23)24)22-9-8-21-18(22)13-4-3-7-20-11-13/h1-9,11,14H,10,12H2
InChIKeyAXRPDGYIFVARJU-UHFFFAOYSA-N
MW338.80 g/mol
LogP3.58
Rot. Bonds3

About 1-(2-chlorophenyl)-4-(2-pyridin-3-ylimidazol-1-yl)pyrrolidin-2-one

1-(2-chlorophenyl)-4-(2-pyridin-3-ylimidazol-1-yl)pyrrolidin-2-one (PubChem CID 70716243) has the molecular formula C18H15ClN4O and a molecular weight of 338.80 g/mol. Its IUPAC name is 1-(2-chlorophenyl)-4-(2-pyridin-3-ylimidazol-1-yl)pyrrolidin-2-one.

Molecular Properties

Compound Name1-(2-chlorophenyl)-4-(2-pyridin-3-ylimidazol-1-yl)pyrrolidin-2-one
PubChem CID70716243
Molecular FormulaC18H15ClN4O
Molecular Weight338.80 g/mol
Exact Mass338.09
IUPAC Name1-(2-chlorophenyl)-4-(2-pyridin-3-ylimidazol-1-yl)pyrrolidin-2-one
SMILESO=C1CC(n2ccnc2-c2cccnc2)CN1c1ccccc1Cl
InChIInChI=1S/C18H15ClN4O/c19-15-5-1-2-6-16(15)23-12-14(10-17(23)24)22-9-8-21-18(22)13-4-3-7-20-11-13/h1-9,11,14H,10,12H2
InChIKeyAXRPDGYIFVARJU-UHFFFAOYSA-N
XLogP3.58
TPSA51.02 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds3
Heavy Atoms24
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500338.80
LogP ≤ 53.58
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Analyze 1-(2-chlorophenyl)-4-(2-pyridin-3-ylimidazol-1-yl)pyrrolidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(3S)-1-(2-chlorophenyl)-5-oxo-N-(4-pyridin-3-yl-1,3-thiazol-2-yl)pyrrolidine-3-carboxamide
CID 25329053
1-(2-chlorophenyl)-4-[4-(pyridin-3-ylmethyl)piperazine-1-carbonyl]pyrrolidin-2-one
CID 134045069
1-(3-chlorophenyl)-4-[2-(1-methylimidazol-2-yl)imidazol-1-yl]pyrrolidin-2-one
CID 154568444
1-(2-chlorophenyl)-4-sulfanylpyrrolidin-2-one
CID 168710154
4-[2-(furan-2-yl)imidazol-1-yl]-1-phenylpyrrolidin-2-one
CID 156587008
(3S)-1-(2-chlorophenyl)-5-oxopyrrolidine-3-carboxamide
CID 42579807
trans-(1R,2R)-2-(2-pyridin-3-ylimidazol-1-yl)cyclohexan-1-ol
CID 133264534
N-[(3R)-1-(2-chlorophenyl)-5-oxopyrrolidin-3-yl]-2-fluoropyridine-4-carboxamide
CID 95323518
1-(2-chlorophenyl)-5-oxo-N-(2-phenylphenyl)pyrrolidine-3-carboxamide
CID 112789630
1-(2-chlorophenyl)-4-(4-methylpiperazine-1-carbonyl)pyrrolidin-2-one
CID 84504102
1-(2-chlorophenyl)-N-[5-[1-(difluoromethyl)imidazol-2-yl]-4-methyl-1,3-thiazol-2-yl]-5-oxopyrrolidine-3-carboxamide
CID 24626207
1-(2-chlorophenyl)-N-[(4-methyl-1,3-thiazol-5-yl)methyl]-5-oxopyrrolidine-3-carboxamide
CID 136523864

Frequently Asked Questions

What is the IUPAC name of 1-(2-chlorophenyl)-4-(2-pyridin-3-ylimidazol-1-yl)pyrrolidin-2-one?
The IUPAC name of 1-(2-chlorophenyl)-4-(2-pyridin-3-ylimidazol-1-yl)pyrrolidin-2-one (CID 70716243) is 1-(2-chlorophenyl)-4-(2-pyridin-3-ylimidazol-1-yl)pyrrolidin-2-one.
What is the SMILES notation for 1-(2-chlorophenyl)-4-(2-pyridin-3-ylimidazol-1-yl)pyrrolidin-2-one?
The canonical SMILES for 1-(2-chlorophenyl)-4-(2-pyridin-3-ylimidazol-1-yl)pyrrolidin-2-one is O=C1CC(n2ccnc2-c2cccnc2)CN1c1ccccc1Cl.
What is the InChIKey of 1-(2-chlorophenyl)-4-(2-pyridin-3-ylimidazol-1-yl)pyrrolidin-2-one?
The InChIKey is AXRPDGYIFVARJU-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H15ClN4O/c19-15-5-1-2-6-16(15)23-12-14(10-17(23)24)22-9-8-21-18(22)13-4-3-7-20-11-13/h1-9,11,14H,10,12H2.
What are the key properties of 1-(2-chlorophenyl)-4-(2-pyridin-3-ylimidazol-1-yl)pyrrolidin-2-one?
1-(2-chlorophenyl)-4-(2-pyridin-3-ylimidazol-1-yl)pyrrolidin-2-one has a molecular weight of 338.80 g/mol, XLogP of 3.58, 3 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(2-chlorophenyl)-4-(2-pyridin-3-ylimidazol-1-yl)pyrrolidin-2-one is sourced from PubChem (CID 70716243), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).